Command Palette
Search for a command to run...
Niva Bupa Health Insurance
NSE: NIVABUPABSE: 544286BANKING AND FINANCEGENERAL INSURANCE
Market Cap
--
P/E Ratio
0.00
P/B Ratio
0.00
ROE
0.00%
ROA
0.00%
Debt/Equity
0.00
Book Value
₹0.0
EPS
₹0.0
About Niva Bupa Health Insurance
Niva Bupa Health Insurance Company operates as an insurance company. The Company offers a wide range of health and life, travel, and corporate insurance plans to individuals and organizations. Max Bupa Health Insurance serves customers in India.
Niva Bupa Health Insurance Company Limited was initially incorporated as `Max Bupa Health Insurance Limited' at New Delhi, Delhi as a Public Limited Company dated September 5, 2008 and granted its Certificate for Commencement of Business on December 23, 2008 by the Deputy Registrar of Companies, NCT of Delhi and Haryana. Thereafter, Company changed its name to `Max Bupa Health Insurance Company Limited', dated July 30, 2009 and again to `Niva Bupa Health Insurance Company Limited' pursuant to a fresh Certificate of Incorporation dated July 5, 2021 issued by the Registrar of Companies, Delhi. The Company is a standalone health insurer (SAHI) strategically focused on the retail health market. The Company underwrites primarily Health Insurance business which includes Personal accident, Critical illness and Travel. The Company is a joint venture between Bupa Singapore Holdings Pte Ltd, Singapore and Fettle Tone LLP. Bupa Singapore Holdings Pte Ltd is the holding Company with 63% shareholding. The Company incorporated in September 2008 as a joint venture between Max India Limited and Bupa Singapore Holdings Pte. Ltd. The Company obtained regulatory approval to undertake Health Insurance business on 15th February 2010 from Insurance Regulatory and Development Authority of India (IRDAI and started selling Policies in March 2010. Bupa Singapore Holdings Pte. Ltd. increased its shareholding in the Company from 26% to 49% in July 2016. Through acquisition of Equity Shares of the Company from Max India Limited and Bupa Singapore Pte. Ltd., Fettle Tone LLP became a shareholder in the Company in 2019. The Company became a subsidiary of Bupa Singapore Holdings Pte. Ltd. by acquiring 366,381,439 Equity Shares of the Company from Fettle Tone LLP in 2024. The Company launched the initial public offer of 297,297,296 equity shares of face value of Rs 10 each, by raising funds aggregating to Rs 2200 Cr, comprising a fresh issue of 108,108,108 equity shares aggregating to Rs 800 Cr and offer for sale of 189,189,188 equity shares aggregating to Rs 1400 Cr in November, 2024. The Company's Retail Health Market Share rose to 9.4% up from 9.1% in FY 2025. It launched Rise, new health insurance product with innovative features like Flexi-pay, Return, Smart Cash & Unlimited Digital Consultations in 2025.
Price Action • NIVABUPA
Financial Statements
Consolidated & Standalone Reports
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|---|
Total Revenue | 5,885.75 | 5,529.7 | 4,336.26 | 3,227.32 | 2,158.7 | 1,413.08 |
Operating Expenses | 5,789.15 | 5,227.91 | 4,198.55 | 3,164.41 | 2,318.8 | 1,434.82 |
Operating Profit | 80.78 | 146.37 | -83.08 | -311.33 | -441.45 | -252.21 |
Operating Margin (%) | - | 2.65 | -1.92 | -9.65 | -20.45 | -17.85 |
Total Expenses | - | 5,316.18 | 4,254.41 | 3,214.78 | 2,355.22 | 1,462.82 |
EBITDA | - | 301.79 | 137.71 | 62.92 | -160.1 | -21.75 |
EBITDA Margin (%) | - | 5.46 | 3.18 | 1.95 | -7.42 | -1.54 |
Interest Expenses | 0 | 63.66 | 26.47 | 18.38 | 9.66 | 5.94 |
Depreciation | 0 | 24.61 | 29.39 | 31.99 | 26.76 | 22.05 |
Profit Before Tax (PBT) | 92.61 | 213.52 | 81.85 | 12.54 | -196.52 | -49.74 |
Tax Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
PAT Before Extraordinary Items | - | 213.52 | 81.85 | 12.54 | -196.52 | -49.74 |
Net Profit | 92.61 | 213.52 | 81.85 | 12.54 | -196.52 | -49.74 |
Net Profit Margin (%) | - | 3.97 | 1.98 | 0.43 | -10.46 | -4.2 |
EPS (Adjusted) | - | 1.16 | 0.44 | 0.07 | -1.06 | -0.27 |
Valuation & Key Ratios
Performance Metrics
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|---|
Book Value Per Share | - | 16.72 | 12.06 | 5.48 | 3.59 | 4.27 |
Return on Assets (ROA) % | - | 2.18 | 1.32 | 0.32 | -7.17 | -2.61 |
Return on Equity (ROE) % | - | 6.99 | 3.99 | 1.51 | -38.86 | -8.62 |
Return on Capital Employed (ROCE) % | - | 8.37 | 4.7 | 2.86 | -24.72 | -7.59 |
Profitability Ratios | - | - | - | - | - | - |
Liquidity Ratios | - | - | - | - | - | - |
Valuation Ratios | - | - | - | - | - | - |
Debt to Equity Ratio | - | 0.08 | 0.12 | 0.3 | 0.49 | 0 |
Featured Insight
No recent news available
Key People
D
Dr. Bhabatosh Mishra
Director,Chief Operating Officer
M
Mr. Padmesh Nair
Director(Operations,Customer Service)
M
Mr. Tarun Katyal
Director(Chief Sustainability,Hr Officer)
M
Mr. Rajat Bajaj
Director,Chief(Legal.,Compliance,Secretarial And Regulatory Affairs)
M
Mr. Nimish Agarwal
Director,Cmo,Head(Digital Sbu)
M
Mr. Dhiresh Rustogi
Director,Chief Technology Officer
M
Mr. Vikas Jain
Executive Vice President,Chief Investment Officer
M
Mr. Manish Sen
Executive Vice President
M
Ms. Smriti Manchanda
Senior Vice President,Head(Internal Audit)
M
Ms. Joanne Elizabeth Woods
Chief Risk Officer,Senior Vice President
R
Rajat Sharma
Company Secretary,Compliance Officer
V
Vishwanath Mahendra
Executive Director,Whole Time Director,Chief Financial Officer
A
Ankur Kharbanda
Executive Director,Whole Time Director,Chief Business Officer
R
Ramachandran Krishnan
Executive Director,Managing Director,Chief Executive Officer